A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

NCT05209984 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic change in development priorities

Conditions

Overweight
Obesity

Interventions

DRUG: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg
DRUG: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg
DRUG: SIB Group Sibus (Sibutramine) 15mg
DRUG: Placebo Group

Sponsor

Eurofarma Laboratorios S.A.